Mutations in the coding regions of the hepatocyte nuclear factor 4 alpha in Iranian families with maturity onset diabetes of the young

被引:0
作者
Seyed Morteza Taghavi
Seyedeh Seddigheh Fatemi
Houshang Rafatpanah
Rashin Ganjali
Jalil Tavakolafshari
Narges Valizadeh
机构
[1] Mashhad University of Medical Sciences,Internal Medicine Department, Ghaem Hospital & Endocrine Research Center
[2] Mashhad University of Medical Sciences,Immunogenetics Department, Immunology Research Center, Bu
[3] Bu Ali Square,Ali Research Center
[4] Ferdowsi Square,Microbiology and Virology Department, Bu
[5] Mashhad University of Medical Sciences,Ali Research Center
[6] Bu Ali Square,undefined
[7] Ferdowsi Square,undefined
来源
Cardiovascular Diabetology | / 8卷
关键词
Maturity Onset Diabetes; Fasting Blood Sugar; Oral Hypoglycemic Agent; Fast Serum Insulin; Iranian Patient;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatocyte nuclear factor 4α (HNF4α) is a nuclear receptor involved in glucose homeostasis and is required for normal β cell function. Mutations in the HNF4α gene are associated with maturity onset diabetes of the young type 1 (MODY1). The aim of the present study was to determine the prevalence and nature of mutations in HNF4α gene in Iranian patients with a clinical diagnosis of MODY and their family members. Twelve families including 30 patients with clinically MODY diagnosis and 21 members of their family were examined using PCR-RFLP method and in case of mutation confirmed by sequencing techniques. Fifty age and sex matched subjects with normal fasting blood sugar (FBS) and Glucose tolerance test (GTT) were constituted the control group and investigated in the similar pattern. Single mutation of V255M in the HNF4α gene was detected. This known mutation was found in 8 of 30 patients and 3 of 21 individuals in relatives. Fifty healthy control subjects did not show any mutation. Here, it is indicated that the prevalence of HNF4α mutation among Iranian patients with clinical MODY is considerable. This mutation was present in 26.6% of our patients, but nothing was found in control group. In the family members, 3 subjects with the age of ≤25 years old carried this mutation. Therefore, holding this mutation in this range of age could be a predisposing factor for developing diabetes in future.
引用
收藏
相关论文
共 194 条
[91]  
Saad M(undefined)undefined undefined undefined undefined-undefined
[92]  
Warram JH(undefined)undefined undefined undefined undefined-undefined
[93]  
Montminy M(undefined)undefined undefined undefined undefined-undefined
[94]  
Krolewski AS(undefined)undefined undefined undefined undefined-undefined
[95]  
Barrio R(undefined)undefined undefined undefined undefined-undefined
[96]  
Bellanne-Chantelot C(undefined)undefined undefined undefined undefined-undefined
[97]  
Moreno JC(undefined)undefined undefined undefined undefined-undefined
[98]  
Morel V(undefined)undefined undefined undefined undefined-undefined
[99]  
Calle H(undefined)undefined undefined undefined undefined-undefined
[100]  
Alonso M(undefined)undefined undefined undefined undefined-undefined